Shares of LumiraDx Limited (NASDAQ: LMDX) fell sharply in pre-market trading after the company agreed to sell its point-of-care technology platform to Roche.
LumiraDx shares dipped 19.7% to $0.0517 in pre-market trading.
Here are some other stocks moving in pre-market trading.
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 50 points on Friday.
The Dow traded down 0.17% to 37,644.68 while the NASDAQ fell 0.48% to 15,022.70. The S&P 500 also fell, dropping, 0.33% to 4,767.78.
U.S. stocks turned lower midway through trading, with the Nasdaq Composite falling more than 100 points on Friday.
The Dow traded down 0.34% to 37,583.72 while the NASDAQ fell 0.73% to 14,984.98. The S&P 500 also fell, dropping, 0.47% to 4,760.73.
U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining around 10 points on Friday.
Following the market opening Friday, the Dow traded up 0.03% to 37,723.19 while the NASDAQ rose 0.02% to 15,098.01. The S&P 500 also rose, gaining, 0.05% to 4,785.65.
Shares of Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) rose sharply in today’s pre-market trading session.
Titan Pharmaceuticals said its Board of Directors has approved a 1-for-20 reverse stock split.
Titan Pharmaceuticals shares jumped 15.2% to $0.38 in pre-market trading.